Zhang L - Search Results

1

Discovery of potent histone deacetylase inhibitors with modified phenanthridine caps.

Fan W, Zhang L, Wang X, Jia H, Zhang L. Fan W, et al. Among authors: zhang l. J Enzyme Inhib Med Chem. 2021 Dec;36(1):707-718. doi: 10.1080/14756366.2021.1892089. J Enzyme Inhib Med Chem. 2021. PMID: 33663315 Free PMC article.

2

Orally active purine-based inhibitors of the heat shock protein 90.

Biamonte MA, Shi J, Hong K, Hurst DC, Zhang L, Fan J, Busch DJ, Karjian PL, Maldonado AA, Sensintaffar JL, Yang YC, Kamal A, Lough RE, Lundgren K, Burrows FJ, Timony GA, Boehm MF, Kasibhatla SR. Biamonte MA, et al. Among authors: zhang l. J Med Chem. 2006 Jan 26;49(2):817-28. doi: 10.1021/jm0503087. J Med Chem. 2006. PMID: 16420067

3

7'-substituted benzothiazolothio- and pyridinothiazolothio-purines as potent heat shock protein 90 inhibitors.

Zhang L, Fan J, Vu K, Hong K, Le Brazidec JY, Shi J, Biamonte M, Busch DJ, Lough RE, Grecko R, Ran Y, Sensintaffar JL, Kamal A, Lundgren K, Burrows FJ, Mansfield R, Timony GA, Ulm EH, Kasibhatla SR, Boehm MF. Zhang L, et al. J Med Chem. 2006 Aug 24;49(17):5352-62. doi: 10.1021/jm051146h. J Med Chem. 2006. PMID: 16913725

4

Synthesis and biological evaluation of novel aromatic-heterocyclic biphenyls as potent anti-leukemia agents.

Dong J, Pan X, Wang J, Su P, Zhang L, Wei F, Zhang J. Dong J, et al. Among authors: zhang l, zhang j. Eur J Med Chem. 2015 Aug 28;101:780-9. doi: 10.1016/j.ejmech.2015.07.015. Epub 2015 Jul 10. Eur J Med Chem. 2015. PMID: 26231079

5

Expanding the structural diversity of diarylureas as multi-target tyrosine kinase inhibitors.

Shan Y, Wang C, Zhang L, Wang J, Wang M, Dong Y. Shan Y, et al. Among authors: zhang l. Bioorg Med Chem. 2016 Feb 15;24(4):750-8. doi: 10.1016/j.bmc.2015.12.038. Epub 2015 Dec 23. Bioorg Med Chem. 2016. PMID: 26753815

6

Discovery of novel 9H-purin derivatives as dual inhibitors of HDAC1 and CDK2.

Yu Y, Ran D, Jiang J, Pan T, Dan Y, Tang Q, Li W, Zhang L, Gan L, Gan Z. Yu Y, et al. Among authors: zhang l. Bioorg Med Chem Lett. 2019 Aug 15;29(16):2136-2140. doi: 10.1016/j.bmcl.2019.06.059. Epub 2019 Jun 29. Bioorg Med Chem Lett. 2019. PMID: 31272794

7

Discovery of indole-3-butyric acid derivatives as potent histone deacetylase inhibitors.

Chen Y, Zhang L, Zhang L, Jiang Q, Zhang L. Chen Y, et al. Among authors: zhang l. J Enzyme Inhib Med Chem. 2021 Dec;36(1):425-436. doi: 10.1080/14756366.2020.1870457. J Enzyme Inhib Med Chem. 2021. PMID: 33445997 Free PMC article.

8

Santacruzamate A Compositions, Analogs and Methods of Use: A Patent Evaluation of WO 2014/018913 (A2).

Zhang L, Zhang L. Zhang L, et al. Recent Pat Anticancer Drug Discov. 2021;16(4):469-478. doi: 10.2174/1872212115666210615153507. Recent Pat Anticancer Drug Discov. 2021. PMID: 34132184 Review.

9

Discovery of 2,4-pyrimidinediamine derivatives as potent dual inhibitors of ALK and HDAC.

Pan T, Dan Y, Guo D, Jiang J, Ran D, Zhang L, Tian B, Yuan J, Yu Y, Gan Z. Pan T, et al. Among authors: zhang l. Eur J Med Chem. 2021 Nov 15;224:113672. doi: 10.1016/j.ejmech.2021.113672. Epub 2021 Jun 29. Eur J Med Chem. 2021. PMID: 34237620

10

Discovery of 2-(4-Acrylamidophenyl)-Quinoline-4-Carboxylic Acid Derivatives as Potent SIRT3 Inhibitors.

Hui Q, Li X, Fan W, Gao C, Zhang L, Qin H, Wei L, Zhang L. Hui Q, et al. Among authors: zhang l. Front Chem. 2022 Mar 30;10:880067. doi: 10.3389/fchem.2022.880067. eCollection 2022. Front Chem. 2022. PMID: 35433629 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

124,756 results

Search Page